NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

Estimated Value: $5,000,000
Open 186 days left Healthcaregrant
Dec 5, 2024
Jan 7, 2027 12:00 AM
Healthcare
grant
...
AI Summary
This grant opportunity (PAR-25-026) from the NHLBI supports early phase clinical trials for therapeutics and/or diagnostics for Heart, Lung, Blood, and Sleep (HLBS) disorders. It utilizes an R61/R33 phased award mechanism and requires a clinical trial.
Line Items
ItemQtyUnitEst. Unit PriceEst. TotalCategory
Early Phase Clinical Trial Services for Therapeutics Development for HLBS Disorders 1 each $1,500,000.00 $1,500,000.00 Medical
Early Phase Clinical Trial Services for Diagnostics Development for HLBS Disorders 1 each $1,500,000.00 $1,500,000.00 Medical
Data Management and Analysis Services for Clinical Trials 1 each $500,000.00 $500,000.00 Professional Services
Regulatory Compliance and Reporting Services for Clinical Trials 1 each $500,000.00 $500,000.00 Professional Services
Patient Recruitment and Retention Services for Clinical Trials 1 each $500,000.00 $500,000.00 Medical
Clinical Trial Site Management Services 1 each $500,000.00 $500,000.00 Medical
Estimated Bid Value$5,000,000.00

Want the full details?

Sign up free to see the agency name, contact info, and the original bid posting link.

Sign Up Free →

Related Bids

Browse More Bids

Healthcare BidsGRANT BidsClosing Soon All Bids